Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice

SIMPLE SUMMARY: We are entering an exciting new phase in the history of non-Hodgkin lymphoma treatment. Advances in monoclonal antibody-based therapies, which began with rituximab in the 1990s but have only recently started to show their full potential, along with the development of cellular therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavarozzi, Rita, Zacchi, Giulia, Pietrasanta, Daniela, Catania, Gioacchino, Castellino, Alessia, Monaco, Federico, Gandolfo, Carolina, Rivela, Paolo, Sofia, Antonella, Schiena, Noemi, Bertassello, Claudia, Limberti, Giulia, Zallio, Francesco, Zanni, Manuela, Ladetto, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670523/
https://www.ncbi.nlm.nih.gov/pubmed/38001657
http://dx.doi.org/10.3390/cancers15225397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670523/
https://www.ncbi.nlm.nih.gov/pubmed/38001657
http://dx.doi.org/10.3390/cancers15225397

Ejemplares similares